These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25306891)

  • 1. Predictive value of serum apolipoprotein B/apolipoprotein A-I ratio in metabolic syndrome risk: a Chinese cohort study.
    Chou YC; Kuan JC; Bai CH; Yang T; Chou WY; Hsieh PC; You SL; Hwang LC; Chen CH; Wei CY; Sun CA
    Endocrine; 2015 Jun; 49(2):404-14. PubMed ID: 25306891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study.
    Jing F; Mao Y; Guo J; Zhang Z; Li Y; Ye Z; Ding Y; Wang J; Jin M; Chen K
    Lipids Health Dis; 2014 May; 13():81. PubMed ID: 24886173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of apolipoprotein B/A1 ratio in the diagnosis of metabolic syndrome in a Korean population.
    Jung CH; Hwang JY; Yu JH; Shin MS; Bae SJ; Park JY; Kim HK; Lee WJ
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):699-706. PubMed ID: 22211563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study.
    Qin G; Tu J; Zhang C; Tang X; Luo L; Wu J; Liu L; Lu W; Tao L; Shen S; Das UN; Pan W
    Lipids Health Dis; 2015 Apr; 14():24. PubMed ID: 25885111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the apolipoprotein B/apolipoprotein A-I ratio and low-density lipoprotein cholesterol with insulin resistance in a Chinese population with abdominal obesity.
    Ying X; Qian Y; Jiang Y; Jiang Z; Song Z; Zhao C
    Acta Diabetol; 2012 Dec; 49(6):465-72. PubMed ID: 22965469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population.
    Sierra-Johnson J; Fisher RM; Romero-Corral A; Somers VK; Lopez-Jimenez F; Ohrvik J; Walldius G; Hellenius ML; Hamsten A
    Eur Heart J; 2009 Mar; 30(6):710-7. PubMed ID: 18676970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.
    Kim SW; Jee JH; Kim HJ; Jin SM; Suh S; Bae JC; Kim SW; Chung JH; Min YK; Lee MS; Lee MK; Kim KW; Kim JH
    Int J Cardiol; 2013 Oct; 168(3):2678-83. PubMed ID: 23545148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans.
    Enkhmaa B; Anuurad E; Zhang Z; Pearson TA; Berglund L
    Am J Cardiol; 2010 Nov; 106(9):1264-9. PubMed ID: 21029822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.
    Wallenfeldt K; Bokemark L; Wikstrand J; Hulthe J; Fagerberg B
    Stroke; 2004 Oct; 35(10):2248-52. PubMed ID: 15345795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.
    Belfki H; Ben Ali S; Bougatef S; Ben Ahmed D; Haddad N; Jmal A; Abdennebi M; Ben Romdhane H
    Exp Mol Pathol; 2011 Oct; 91(2):622-5. PubMed ID: 21801720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G; Jungner I; Holme I; Aastveit AH; Kolar W; Steiner E
    Lancet; 2001 Dec; 358(9298):2026-33. PubMed ID: 11755609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and carotid intima-media thickness in young adults: roles of apolipoprotein B, apolipoprotein A-I, C-reactive protein, and secretory phospholipase A2: the cardiovascular risk in young Finns study.
    Mattsson N; Magnussen CG; Rönnemaa T; Mallat Z; Benessiano J; Jula A; Taittonen L; Kähönen M; Juonala M; Viikari JS; Raitakari OT
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1861-6. PubMed ID: 20539018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term risk of a major cardiovascular event by apoB, apoA-1, and the apoB/apoA-1 ratio-Experience from the Swedish AMORIS cohort: A cohort study.
    Walldius G; de Faire U; Alfredsson L; Leander K; Westerholm P; Malmström H; Ivert T; Hammar N
    PLoS Med; 2021 Dec; 18(12):e1003853. PubMed ID: 34851955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B/apolipoprotein A-I ratio and apolipoprotein B: long-term predictors of myocardial infarction in initially healthy middle-aged men--a 13-year follow-up.
    Schmidt C; Bergström G
    Angiology; 2014 Nov; 65(10):901-5. PubMed ID: 24277914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes.
    Wang W; Khan S; Blackett P; Alaupovic P; Lee E
    J Clin Lipidol; 2013; 7(1):38-42. PubMed ID: 23351581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: a 5-years' follow-up study.
    Ryoo JH; Park SK
    Atherosclerosis; 2013 Feb; 226(2):496-501. PubMed ID: 23273962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.
    Zheng KH; Arsenault BJ; Kaiser Y; Khaw KT; Wareham NJ; Stroes ESG; Boekholdt SM
    J Am Heart Assoc; 2019 Aug; 8(16):e013020. PubMed ID: 31407609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
    Albers JJ; Slee A; O'Brien KD; Robinson JG; Kashyap ML; Kwiterovich PO; Xu P; Marcovina SM
    J Am Coll Cardiol; 2013 Oct; 62(17):1575-9. PubMed ID: 23973688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.
    Zheng S; Han T; Xu H; Zhou H; Ren X; Wu P; Zheng J; Wang L; Zhang M; Jiang Y; Chen Y; Qiu H; Liu W; Hu Y
    BMJ Open; 2017 Jan; 7(1):e014038. PubMed ID: 28110289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.